» Articles » PMID: 30566312

Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome

Citing Articles

How (Ultra-)Rare Gene Variants Improve Our Understanding of More Common Autoimmune and Inflammatory Diseases.

Belot A, Tusseau M, Cognard J, Georgin-Lavialle S, Boursier G, Hedrich C ACR Open Rheumatol. 2025; 7(2):e70003.

PMID: 39964335 PMC: 11834591. DOI: 10.1002/acr2.70003.


Increased interferon I signaling, DNA damage response and evidence of T-cell exhaustion in a patient with combined interferonopathy (Aicardi-Goutières Syndrome, AGS) and cohesinopathy (Cornelia de Lange Syndrome, CdLS).

Boiu S, Paschalidis N, Sentis G, Manolakou T, Nezos A, Gialitakis M Pediatr Rheumatol Online J. 2025; 23(1):11.

PMID: 39871364 PMC: 11770959. DOI: 10.1186/s12969-024-01050-7.


Domain Mobility in the ORF2p Complex Revealed by Molecular Dynamics Simulations and Big Data Analysis.

Kulakova A, Khrenova M, Zvereva M, Polyakov I Int J Mol Sci. 2025; 26(1).

PMID: 39795935 PMC: 11719894. DOI: 10.3390/ijms26010073.


Human Endogenous Retroviruses Expression in Autoimmunity.

Viret C, Bynoe M Yale J Biol Med. 2024; 97(4):521-528.

PMID: 39703611 PMC: 11650914. DOI: 10.59249/OIKF8301.


Reverse transcriptase inhibitors in Aicardi-Goutières syndrome: A crossover clinical trial.

Crow Y, Briggs T, Eleftheriou D, Parida A, Battison C, Giddings A Dev Med Child Neurol. 2024; .

PMID: 39630935 PMC: 7617231. DOI: 10.1111/dmcn.16199.